361 related articles for article (PubMed ID: 8267609)
1. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
2. Substituted 3-oxo-1,2,5-thiadiazolidine 1,1-dioxides: a new class of potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G.
Groutas WC; Kuang R; Venkataraman R
Biochem Biophys Res Commun; 1994 Jan; 198(1):341-9. PubMed ID: 8292039
[TBL] [Abstract][Full Text] [Related]
3. Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study.
Groutas WC; Venkataraman R; Chong LS; Yoder JE; Epp JB; Stanga MA; Kim EH
Bioorg Med Chem; 1995 Feb; 3(2):125-8. PubMed ID: 7796046
[No Abstract] [Full Text] [Related]
4. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
[TBL] [Abstract][Full Text] [Related]
5. Synthetic inhibitors of human granulocyte elastase, Part 4. Inhibition of human granulocyte elastase and cathepsin G by non-steroidal anti-inflammatory drugs (NSAID)s.
Lentini A; Ternai B; Ghosh P
Biochem Int; 1987 Dec; 15(6):1069-78. PubMed ID: 3440020
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of human leukocyte elastase and cathepsin G. Sequence variants of squash seed protease inhibitor with altered protease selectivity.
McWherter CA; Walkenhorst WF; Campbell EJ; Glover GI
Biochemistry; 1989 Jul; 28(14):5708-14. PubMed ID: 2775732
[No Abstract] [Full Text] [Related]
7. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
Petersen LC; Bjørn SE; Nordfang O
Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
[TBL] [Abstract][Full Text] [Related]
8. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of human leukocyte elastase and bovine alpha-chymotrypsin by novel heterocycles.
Ashe BM; Clark RL; Jones H; Zimmerman M
J Biol Chem; 1981 Nov; 256(22):11603-6. PubMed ID: 6913580
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils.
Groutas WC; Huang H; Epp JB; Venkataraman R; McClenahan JJ; Tagusagawa F
Biochim Biophys Acta; 1994 Nov; 1227(3):130-6. PubMed ID: 7986820
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
12. [An effective single-stage method of obtaining elastase and cathepsin G from human leukocytes].
Neshkova EA; Dotsenko VL; Larionova NI; Iarovaia GA
Biokhimiia; 1993 Dec; 58(12):1886-92. PubMed ID: 8292650
[TBL] [Abstract][Full Text] [Related]
13. Pseudosaccharin amine derivatives: synthesis and elastase inhibitory activity.
Rode HB; Sprang T; Besch A; Loose J; Otto HH
Pharmazie; 2005 Oct; 60(10):723-31. PubMed ID: 16259117
[TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of human leukocyte elastase and cathepsin G by saccharin derivatives.
Groutas WC; Houser-Archield N; Chong LS; Venkataraman R; Epp JB; Huang H; McClenahan JJ
J Med Chem; 1993 Oct; 36(21):3178-81. PubMed ID: 8230105
[TBL] [Abstract][Full Text] [Related]
15. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
16. A new class of heterocyclic serine protease inhibitors. Inhibition of human leukocyte elastase, porcine pancreatic elastase, cathepsin G, and bovine chymotrypsin A alpha with substituted benzoxazinones, quinazolines, and anthranilates.
Teshima T; Griffin JC; Powers JC
J Biol Chem; 1982 May; 257(9):5085-91. PubMed ID: 7040392
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inhibitors of serine proteinases based on the Gabriel-Colman rearrangement.
Groutas WC; Chong LS; Venkataraman R; Epp JB; Kuang RZ; Brubaker MJ; Houser-Archield N; Huang H; McClenahan JJ
Biochem Biophys Res Commun; 1993 Aug; 194(3):1491-9. PubMed ID: 8352807
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.
Kettner CA; Shenvi AB
J Biol Chem; 1984 Dec; 259(24):15106-14. PubMed ID: 6392293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
